A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin
Open Access
- 14 December 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 8 (12) , 1695-1703
Abstract
Proximity-based strategies to degrade proteins have enormous therapeutic potential in medicine, but the technologies are limited to proteins for which small molecule ligands exist. The identification of such ligands for therapeutically relevant but "undruggable" proteins remains challenging. Herein, we employed yeast surface display of synthetic nanobodies to identify a protein ligand selective for BCL11A, a critical repressor of fetal globin gene transcription. Fusion of the nanobody to a cell-permeant miniature protein and an E3 adaptor creates a degrader that depletes cellular BCL11A in differentiated primary erythroid precursor cells, thereby inducing the expression of fetal hemoglobin, a modifier of clinical severity of sickle cell disease and β-thalassemia. Our strategy provides a means of fetal hemoglobin induction through reversible, temporal modulation of BCL11A. Additionally, it establishes a new paradigm for the targeted degradation of previously intractable proteins.Keywords
All Related Versions
Funding Information
- Damon Runyon Cancer Research Foundation (DRG-2363-19)
- Biological and Environmental Research
- National Heart, Lung, and Blood Institute (NIH 5R01HL032259-39)
- Hellman Foundation
- National Institute of General Medical Sciences (P30GM133894)
This publication has 35 references indexed in Scilit:
- Nanobody-targeted E3-ubiquitin ligase complex degrades nuclear proteinsScientific Reports, 2015
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesisNature, 2015
- Phthalimide conjugation as a strategy for in vivo target protein degradationScience, 2015
- An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin LevelScience, 2013
- Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood CellsPLOS ONE, 2013
- Arginine Topology Controls Escape of Minimally Cationic Proteins from Early Endosomes to the CytoplasmChemistry & Biology, 2012
- Fluorescent fusion protein knockout mediated by anti-GFP nanobodyNature Structural & Molecular Biology, 2011
- Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11AScience, 2008
- The BCL11 gene family: involvement of BCL11A in lymphoid malignanciesBlood, 2001
- Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradationProceedings of the National Academy of Sciences of the United States of America, 2001